BioCentury
ARTICLE | Company News

BMY, Otsuka submit aripiprazole NDA

November 7, 2001 8:00 AM UTC

Bristol-Myers (BMY) and partner Otsuka Pharmaceutical (Tokyo, Japan) submitted an NDA with the FDA for aripiprazole second generation antipsychotic to treat schizophrenia. In May the partners reported...